Literature DB >> 19655096

[Outside-in. Probiotic topical agents].

T Volz1, T Biedermann.   

Abstract

In dermatology probiotic microorganisms have primarily been used orally for the prophylaxis and treatment of atopic disorders. In contrast to the successes achieved for gastrointestinal disorders, positive effects for atopic dermatitis only have been found in a few studies. New insights could now fundamentally change the impact of probiotics on dermatology. Probiotics are - like microflora of the skin - non-pathogenic microbes, which do not induce inflammatory responses in the skin. Common pathways for probiotics, non-pathogenic microbes, and microflora are characterized, in order to facilitate their more effective therapeutic use. These microbes display a majority of their effects directly at the site of application and thereby induce natural defense mechanisms. However, promotion of immunological tolerance is just as important in producing positive effects. Tolerance of the resident flora on surface organs developed during evolution and the mechanisms of action are multifaceted. Therefore, the topical application of probiotics and non-pathogenic microbes for prophylaxis and therapy of overwhelming cutaneous pro-inflammatory immune reactions is very promising. Results of recent clinical trials already have demonstrated the efficacy of this new therapeutic concept.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655096     DOI: 10.1007/s00105-009-1755-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  47 in total

1.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

Authors:  B Schittek; R Hipfel; B Sauer; J Bauer; H Kalbacher; S Stevanovic; M Schirle; K Schroeder; N Blin; F Meier; G Rassner; C Garbe
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

Review 2.  Tissue targeting of T cells by DCs and microenvironments.

Authors:  Jan C Dudda; Stefan F Martin
Journal:  Trends Immunol       Date:  2004-08       Impact factor: 16.687

Review 3.  TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin.

Authors:  Tilo Biedermann; Martin Röcken; José M Carballido
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

4.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

5.  Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Authors:  W Kruis; E Schütz; P Fric; B Fixa; G Judmaier; M Stolte
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

6.  Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.

Authors:  Günther Weindl; Julian R Naglik; Susanne Kaesler; Tilo Biedermann; Bernhard Hube; Hans Christian Korting; Martin Schaller
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

8.  Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis.

Authors:  Joohee Lee; David Seto; Leonard Bielory
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

Review 9.  Dendritic cells--why can they help and hurt us.

Authors:  Knut Schäkel
Journal:  Exp Dermatol       Date:  2009-01-24       Impact factor: 3.960

Review 10.  Probiotics for the prevention or treatment of allergic diseases.

Authors:  Susan L Prescott; Bengt Björkstén
Journal:  J Allergy Clin Immunol       Date:  2007-06-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.